SCHEMBL18353099

SCHEMBL18353099

C=CC(=O)OCCOc1ccc(C2(c3ccc(OCCOC(=O)C=C)c(-c4nc5ccccc5s4)c3)c3ccccc3-c3cc4ccccc4cc32)cc1-c1nc2ccccc2s1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.36
MAPT P10636 10/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
ALDH1A1 P00352 2/20 0.34
KDM4E B2RXH2 1/20 0.34
HCRTR1 O43613 1/20 0.34
GLA P06280 1/20 0.34
GAA P10253 1/20 0.34
RXFP1 Q9HBX9 3/20 0.34
TP53 P04637 5/20 0.34
LMNA P02545 2/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC2 Q92769 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
POLB P06746 1/20 0.34
NPY1R P25929 1/20 0.33
NPY2R P49146 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18353688 0.95 THRB (0.35) THRBMAPTMEN1KMT2AALDH1A1
SCHEMBL18353820 0.90 THRB (0.35) THRBMAPTTP53HDAC1HDAC2
SCHEMBL18353826 0.89 PPARD (0.37) THRBMAPTMEN1KMT2AALDH1A1
SCHEMBL18353756 0.88 THRB (0.38) THRBMAPTMEN1KMT2AALDH1A1
SCHEMBL18353770 0.86 MAPT (0.33) THRBMAPTMEN1KMT2AALDH1A1
SCHEMBL18353703 0.84 THRB (0.41) THRBMAPTMEN1KMT2AALDH1A1
SCHEMBL24477830 0.84 THRB (0.45) THRBMAPTMEN1KMT2AALDH1A1
SCHEMBL18353101 0.82 THRB (0.39) THRBMAPTKDM4ERXFP1TP53
SCHEMBL18353243 0.82 THRB (0.37) THRBMAPTMEN1KMT2AALDH1A1
SCHEMBL18353704 0.82 THRB (0.37) THRBMAPTKDM4ERXFP1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9902794-B2 Curable composition, optical component and compound FUJIFILM CORPORATION (JP) 2018-02-27 US disclosed
US-9902794-B2 Curable composition, optical component and compound FUJIFILM CORPORATION (JP) 2018-02-27 US disclosed
US-20170002124-A1 CURABLE COMPOSITION, OPTICAL COMPONENT AND COMPOUND FUJIFILM CORPORATION (JP) 2017-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170002124-A1 CURABLE COMPOSITION, OPTICAL COMPONENT AND COMPOUND CCNT1, ARPC4, NLRP1 THRB 4156/4885MAPT 183/4885MEN1 2341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.